{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:12:04Z","timestamp":1788999124008,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.urolonc.2015.01.014","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:18:03Z","timestamp":1424737083000},"page":"407-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Hypogonadism and fertility issues following primary treatment for testicular cancer"],"prefix":"10.1016","volume":"33","author":[{"given":"Jan","family":"Oldenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 6","key":"10.1016\/j.urolonc.2015.01.014_bib1","doi-asserted-by":"crossref","first-page":"vi125","DOI":"10.1093\/annonc\/mdt304","article-title":"Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Oldenburg","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib2","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1200\/JCO.2012.43.4431","article-title":"Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up","volume":"30","author":"Haugnes","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0302-2838(03)00263-X","article-title":"Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer","volume":"44","author":"Nord","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib4","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/jnci\/dji339","article-title":"Paternity following treatment for testicular cancer","volume":"97","author":"Brydoy","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2015.01.014_bib5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1200\/JCO.2013.51.2715","article-title":"Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors","volume":"32","author":"Sprauten","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/bmj.321.7264.789","article-title":"Risk of testicular cancer in men with abnormal semen characteristics: cohort study","volume":"321","author":"Jacobsen","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/j.urolonc.2015.01.014_bib7","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.ju.0000177491.98461.aa","article-title":"Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis","volume":"174","author":"Raman","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1093\/humrep\/16.5.972","article-title":"Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects","volume":"16","author":"Skakkebaek","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.urolonc.2015.01.014_bib9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/humrep\/15.2.366","article-title":"High frequency of sub-optimal semen quality in an unselected population of young men","volume":"15","author":"Andersen","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/j.urolonc.2015.01.014_bib10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrendo.2014.97","article-title":"Possible fetal determinants of male infertility","volume":"10","author":"Juul","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2605.2007.00776.x","article-title":"Testicular cancer trends as \u2018whistle blowers\u2019 of testicular developmental problems in populations","volume":"30","author":"Skakkebaek","year":"2007","journal-title":"Int J Androl"},{"key":"10.1016\/j.urolonc.2015.01.014_bib12","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","article-title":"Male hypogonadism","volume":"383","author":"Basaria","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2015.01.014_bib13","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1743-6109.2009.01298.x","article-title":"Sexual function in men treated for testicular cancer","volume":"6","author":"Eberhard","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.urolonc.2015.01.014_bib14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.eururo.2007.02.046","article-title":"Is the sexual function compromised in long-term testicular cancer survivors?","volume":"52","author":"Dahl","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/annonc\/mdl372","article-title":"Components of the metabolic syndrome in long-term survivors of testicular cancer","volume":"18","author":"Haugnes","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib16","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1200\/JCO.2010.29.9362","article-title":"Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study","volume":"28","author":"Haugnes","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib17","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1200\/JCO.2005.02.176","article-title":"The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer","volume":"23","author":"Nuver","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00345-003-0365-9","article-title":"Androgens and male fertility","volume":"21","author":"Dohle","year":"2003","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib19","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1530\/eje.0.1450561","article-title":"Inhibin B in male reproduction: pathophysiology and clinical relevance","volume":"145","author":"Meachem","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib20","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3109\/00365510903380886","article-title":"Reference intervals for serum testosterone, SHBG, LH and FSH in males from the NORIP project","volume":"69","author":"Bjerner","year":"2009","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.urolonc.2015.01.014_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2008.11.004","article-title":"Aging of the human ovary and testis","volume":"299","author":"Perheentupa","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib22","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.ejca.2011.05.026","article-title":"The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer","volume":"47","author":"Bandak","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2015.01.014_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2605.1987.tb00205.x","article-title":"Testicular cancer and fertility","volume":"10","author":"Berthelsen","year":"1987","journal-title":"Int J Androl"},{"key":"10.1016\/j.urolonc.2015.01.014_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000463782","article-title":"Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment","volume":"10","author":"Fossa","year":"1984","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2015.01.014_bib25","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/bjc.2012.471","article-title":"Sperm counts and endocrinological markers of spermatogenesis in long-term survivors of testicular cancer","volume":"107","author":"Brydoy","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urolonc.2015.01.014_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.1997.15.1.239","article-title":"Fertility after chemotherapy for testicular germ cell cancers","volume":"15","author":"Lampe","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:06:56Z","timestamp":1761041216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1078143915000472"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.01.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypogonadism and fertility issues following primary treatment for testicular cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}